Euroopa Liit -
eesti -
EMA (European Medicines Agency)
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - metformin hydrochloride, sitagliptin hydrochloride monohydrate - suhkurtõbi, tüüp 2 - ravimid, mida kasutatakse diabeedi, - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , kolmekordne kombineeritud ravi) lisandina toitumise ja treeningu patsientidel, ebapiisavalt kontrollitud nende maksimaalne talutav annus metformiin ja sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combinati
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin teva õhukese polümeerikattega tablett
teva gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 56tk; 1000mg+50mg 196tk; 1000mg+50mg 14tk; 1000mg+50mg 98tk; 1000mg+50mg 28tk; 1000mg+50mg 60tk; 1000mg+50mg 112tk;
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin teva õhukese polümeerikattega tablett
teva gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 30tk; 850mg+50mg 28tk; 850mg+50mg 60tk; 850mg+50mg 196tk; 850mg+50mg 14tk; 850mg+50mg 112tk; 850mg+50mg 56tk; 850mg+5
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin hydrochloride sandoz gmbh õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 196tk
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin hydrochloride sandoz gmbh õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 168tk
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin hydrochloride sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 168tk; 1000mg+50mg 56tk; 1000mg+50mg 112tk; 1000mg+50mg 100tk; 1000mg+50mg 196tk
Eesti -
eesti -
Ravimiamet
sitagliptin/metformin hydrochloride sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 196tk; 850mg+50mg 14tk; 850mg+50mg 28tk
Eesti -
eesti -
Ravimiamet
metformin hydrochloride/sitagliptin grindeks õhukese polümeerikattega tablett
as grindeks - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 98tk; 850mg+50mg 28tk; 850mg+50mg 56tk
Eesti -
eesti -
Ravimiamet
metformin hydrochloride/sitagliptin grindeks õhukese polümeerikattega tablett
as grindeks - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 28tk; 1000mg+50mg 56tk; 1000mg+50mg 98tk
Eesti -
eesti -
Ravimiamet
metformin aurobindo õhukese polümeerikattega tablett
aurobindo pharma limited - metformiin - õhukese polümeerikattega tablett - 1000mg 90tk; 1000mg 180tk; 1000mg 50tk; 1000mg 60tk; 1000mg 100tk; 1000mg 20tk; 1000mg 70tk; 1000mg 40tk; 1000mg 80tk; 1000mg 30